Show simple item record

dc.creatorMathews, Anna Wildeen
dc.creatorWestphal, Sylvia Paganen
dc.date.accessioned2016-01-08T23:34:07Zen
dc.date.available2016-01-08T23:34:07Zen
dc.date.created2006-02-24en
dc.date.issued2006-02-24en
dc.identifier.bibliographicCitationWall Street Journal 2006 February 24; p. B1, B4en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Tricky+FDA+debate:+should+a+risky+drug+be+approved+again?&title=Wall+Street+Journal&date=2006-02&au=Mathews,+Anna+Wilde;+Westphal,+Sylvia+Paganen
dc.identifier.urihttp://hdl.handle.net/10822/974430en
dc.formatNews Articleen
dc.languageenen
dc.sourceeweb:294162en
dc.subject.classificationDrugs and Drug Industryen
dc.titleTricky FDA Debate: Should a Risky Drug Be Approved Again?en
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885